Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Linezolid
Drug ID BADD_D01295
Description Linezolid is a synthetic antibiotic which is used for the treatment of infections caused by aerobic Gram-positive bacteria. Its effects are bacteriostatic against both enterococci and staphylococci and bactericidal against most isolates of streptococci.[L32965] Linezolid exerts its antibacterial activity by inhibiting the initiation of bacterial protein synthesis - more specifically, it binds to the 23S ribosomal RNA of the 50S subunit[A11227,A199050] and, in doing so, prevents the formation of the 70S initiation complex which is essential for bacterial reproduction. Linezolid was initially approved in 2000 and was the first member of the oxazolidinone antibiotic class.[A233425] A second member of this class, [tedizolid], was approved by the FDA in 2014 and is considered generally more effective and tolerable than its predecessor.
Indications and Usage For the treatment of bacterial infections caused by susceptible strains of vancomycin resistant Enterococcus faecium, Staphylococcal aureus (methicillin resistant and susceptible strains), Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae.
Marketing Status Prescription; Discontinued
ATC Code J01XX08
DrugBank ID DB00601
KEGG ID D00947
MeSH ID D000069349
PubChem ID 441401
TTD Drug ID D07UYO
NDC Product Code 62332-183; 66794-219; 0904-6553; 0009-5137; 59762-1308; 68382-413; 67457-324; 66499-0047; 63323-713; 55111-947; 46708-936; 0781-3431; 0409-4883; 0009-5140; 63629-8576; 73377-115; 65841-166; 60687-309; 57664-683; 66022-0103; 70518-1226; 68578-0009; 66022-0201; 31722-749; 59762-1307; 73309-004; 59285-021; 66794-236; 65427-821; 0054-0319; 65162-777; 46708-861; 72606-001; 70771-1111; 40032-022; 46708-183; 62512-0032; 66022-0206; 0009-4992; 58623-0129; 66298-7131; 55150-242; 66298-5137; 0009-5157; 58032-2009; 67457-843; 66039-825; 66298-5140; 57664-682; 66298-7807; 52562-019; 67877-419; 0009-5138; 0781-3433; 0009-7807; 68724-5135; 25021-169; 0009-5136
Synonyms Linezolid | N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide | Linezolide | Zyvox | U 100766 | 100766, U | PNU-100766 | PNU 100766 | PNU100766 | U-100766 | U100766
Chemical Information
Molecular Formula C16H20FN3O4
CAS Registry Number 165800-03-3
SMILES CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Acidosis14.01.03.0020.002953%
Acute hepatic failure09.01.03.0010.003937%Not Available
Acute respiratory failure22.02.06.001; 14.01.04.0040.003937%Not Available
Agitation19.06.02.001; 17.02.05.012--
Agranulocytosis01.02.03.001--Not Available
Alanine aminotransferase13.03.01.031--Not Available
Alanine aminotransferase increased13.03.01.0030.030187%
Alopecia23.02.02.001--
Altered state of consciousness19.07.01.003; 17.02.04.0010.022640%Not Available
Amylase13.05.01.010--Not Available
Amylase increased13.05.01.009--
Anaemia01.03.02.0010.332059%
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anaphylactic shock24.06.02.004; 10.01.07.0020.007547%Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Anorectal disorder07.03.01.001--Not Available
Anuria20.01.03.0020.011320%Not Available
Anxiety19.06.02.002--
Aplasia08.03.04.003; 03.02.01.002--Not Available
Aplasia pure red cell01.03.03.001; 10.02.01.0030.030187%Not Available
Aplastic anaemia01.03.03.0020.022640%Not Available
Apnoea22.02.01.001--
Arrhythmia02.03.02.001--Not Available
Aspartate aminotransferase13.03.01.032--Not Available
Aspartate aminotransferase increased13.03.01.0060.022640%
Aspiration22.02.07.0070.004922%
Asthenia08.01.01.001--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 13 Pages